Eskola Juhani, Duclos Philippe, Schuster Melanie, MacDonald Noni E
National Institute for Health and Welfare, Finland.
World Health Organization, Switzerland.
Vaccine. 2015 Aug 14;33(34):4215-7. doi: 10.1016/j.vaccine.2015.04.043. Epub 2015 Apr 18.
Based on the concerns about vaccine hesitancy and its impact on vaccine uptake rates and the performance of national immunization programmes, the Strategic Advisory Group of Experts (SAGE) on Immunization Working Group on Vaccine Hesitancy [1], carried out a review, and proposed a set of recommendations directed to the public health community, to WHO and its partners, and to the World Health Organization (WHO) member states. The final recommendations issued by SAGE in October 2014 fall into three categories: (1) those focused on the need to increase the understanding of vaccine hesitancy, its determinants and the rapidly changing challenges it entails; (2) those focused on dealing with the structures and organizational capacity to decrease hesitancy and increase acceptance of vaccines at the global, national and local levels; (3) and those focused on the sharing of lessons learnt and effective practices from various countries and settings as well as the development, validation and implementation of new tools to address hesitancy.
鉴于对疫苗犹豫及其对疫苗接种率和国家免疫规划实施情况的影响的担忧，免疫战略咨询专家组（SAGE）疫苗犹豫问题工作组[1]进行了一次审查，并向公共卫生界、世卫组织及其合作伙伴以及世界卫生组织（WHO）成员国提出了一系列建议。SAGE于2014年10月发布的最终建议分为三类：（1）侧重于需要增进对疫苗犹豫、其决定因素以及所带来的迅速变化的挑战的理解的建议；（2）侧重于在全球、国家和地方层面处理减少犹豫并提高疫苗接受度的结构和组织能力的建议；（3）侧重于分享各国和各环境中吸取的经验教训及有效做法以及开发、验证和实施应对犹豫的新工具的建议。
